Report from the Western Canadian Gastrointestinal Consensus Cancer Conference—Management of Total Neoadjuvant Therapy in Rectal Cancer
Howard J. Lim(BC Cancer Agency), Adnan Zaidi(University of Saskatchewan), Karen Mulder, Shahida Ahmed(CancerCare Manitoba), Duc Le(University of Saskatchewan), Janine M. Davies(Australian Wildlife Conservancy), Bryan Brunet(University of Saskatchewan), Shahid Ahmed(Emory University), Richard M. Lee‐Ying(Alberta Health Services), Aswin Abraham(Alberta Health Services), Pamela Hebbard(University of Manitoba), John Paul McGhie(BC Cancer Agency), Christina Kim, Jason Y. Park(Southwestern Medical Center), Ralph Wong(CancerCare Manitoba), Corinne Doll(University of Calgary), Vallerie Gordon(Memorial Sloan Kettering Cancer Center), Dorie-Anna Dueck(University of Saskatchewan), Kimberly R. Hagel(University of Saskatchewan), Daniel J. Renouf(BC Cancer Agency), Devin Schellenberg(Surrey Place Centre), Carl J. Brown(University of British Columbia)
Cited by 0
Related Papers
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR–S6K pathway
|Mucosal Immunology|2014|1.2k
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Preoperative Treatment of Locally Advanced Rectal Cancer
|New England Journal of Medicine|2023|440